Breaking News

Cambrex Completes First Expansion Phase at Small Molecule API Mfg. Facility in NC

New space adds analytical and chemical development labs totaling 30,000 sq.-ft. and provides future workspace for 85 scientists.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Cambrex has completed the first phase of its $30 million investment in its small molecule active pharmaceutical ingredient (API) manufacturing facility in High Point, NC. The newly constructed space adds analytical and chemical development labs totaling 30,000 square feet and provides future workspace for 85 analytical and chemical development scientists. These labs will support the development of APIs to be manufactured in the facility’s current clinical manufacturing area, as well as the...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters